Skip to main content
. 2023 Jan 1;19(1):204–224. doi: 10.7150/ijbs.78738

Table 5.

Univariate and multivariate Cox regression model of RF+/- on overall survival

Covariate Univariate Multivariate
N HR 95% CI p-value N HR 95% CI p-value
Risk Factor (RF) 74 0.044* 62 0.024*
No RF 17 1.00 Ref. 14 1.00 Ref.
RF+ 17 6.97 1.52-31.88 0.012* 15 18.19 2.08-158.79 0.009*
RF- 40 5.07 1.18-21.78 0.029* 33 8.75 1.09-69.67 0.040*
Treatment 79 0.009* 62 0.001*
Neoadjuvant 17 1.00 Ref. 9 1.00 Ref.
Adjuvant 51 0.29 0.13-0.65 0.003* 42 0.12 0.04-0.38 <0.001*
Other 11 0.69 0.25-1.89 0.479 11 0.15 0.03-0.73 0.020*
Age (≥73years) 83 2.09 1.00-4.37 0.050* 62 4.13 1.27-13.43 0.018*
Tumor size 74 0.026*
T0 2 NA NA NA
T1 31 0.18 0.05-062 0.007*
T2 35 0.16 0.04-0.53 0.003*
T3-T4 5 1.00 Ref.
Prominent inflammation (Yes) 71 0.42 0.12-1.41 0.163

N: number of patients; HR: Hazard Ratio; NA: not available (not possible to calculate)

RF+: [(p-NDRG1(N)+ / NDRG1(N)+) / (p-NDRG1(N)- / NDRG1(N)+)]

RF-: p-NDRG1(N)- / NDRG1(N)-.